| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |